Therapy for Diabetic Gastroparesis

What we are studying

Gastroparesis is a condition that involves problems emptying the stomach. Some symptoms are vomiting, nausea, abdominal pain, and the feeling of being full right away when you start eating. Gastroparesis may also lead to malnutrition and weight loss. Current treatment for gastroparesis generally includes drugs. This study is about another treatment option, the Enterra Therapy Gastric Stimulation System (gastric pacemaker). Enterra Therapy is indicated for the treatment of patients with long term, uncontrolled (not helped by medication) nausea and vomiting.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 70

Eligibility Criteria

  • Vomiting episodes more than 7 per week averaged over previous 12 weeks
  • Documented delayed gastric emptying of solids on 4-hour nuclear scintigraphy study
  • Previous failed response to or intolerance to at least two classes of antiemetic agents and two classes of prokinetic agents

What is involved

  • Participation lasts about one year after surgery
  • Follow-Up visits in the first 2 months after surgery will be indicated by physician
  • Follow-Up visits will also occur at 3 months 6 months and 12 months



Contact Information

Study Coordinator
Anya Brown
[email protected]

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.